Arcadia Biosciences, Inc. — Director's Dealing 2016

Apr 6, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2016-04-04

Reporting Person: Knauf Vic C. (Director, Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-04-04	Common Stock	M	1200	$1.08	Acquired	48334	Direct
2016-04-04	Common Stock	S	1200	$2.975	Disposed	47134	Direct
2016-04-05	Common Stock	M	1653	$1.08	Acquired	48787	Direct
2016-04-05	Common Stock	S	1653	$2.982	Disposed	47134	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-04-04	Employee Stock Option (right to buy)	$1.08	M	1200	Disposed	2018-06-30	Common Stock (1200)	Direct
2016-04-05	Employee Stock Option (right to buy)	$1.08	M	1653	Disposed	2018-06-30	Common Stock (1653)	Direct

Footnotes

F1: The security transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Stock Trading Plan (the "Plan"), adopted by the Reporting Person effective December 15, 2015.

F2: This transaction was executed in multiple trades at prices ranging from $2.97 to $2.99. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: This transaction was executed in multiple trades at prices ranging from $2.97 to $2.99. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4: The option is fully exercisable as of the date hereof.